# US 2006/0154324 A1 · Prostate-specific antigen probes for optical imaging

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2006/0154324 A1
- Document ID: US20060154324A1
- Status: Published application
- Kind: A1
- Application number: 11/325,074
- Filed: 2006-01-04
- Published: 2006-07-13
- Earliest claimed: 2005-01-07
- Assignees: Kaohsiung Medical University
- Inventors: Yun-Ming Wang; Wei-Hsan Chao; Gin-Chung Liu; Jui-Sheng Hsu
- Web page: https://patentgrep.com/patent/US20060154324A1

## CPC

- C07K 9/001: {the peptide sequence having less than 12 amino acids and not being part of a ring structure}
- C07K 7/06: having 5 to 11 amino acids
- C07K 17/08: the carrier being a synthetic polymer
- C07K 2319/00: Fusion polypeptide
- C07K: PEPTIDES (peptides in foodstuffs A23; obtaining protein compositions for foodstuffs, working-up proteins for foodstuffs A23J; preparations for medicinal purposes A61K; peptides containing beta-lactam rings C07D; cyclic dipeptides not having in their molecule any other peptide link than those which form their ring, e.g. piperazine-2,5-diones, C07D; ergot alkaloids of the cyclic peptide type C07D519/02; macromolecular compounds having statistically distributed amino acid units in their molecules, i.e. when the preparation does not provide for a specific; but for a random sequence of the amino acid units, homopolyamides and block copolyamides derived from amino acids C08G69/00; macromolecular products derived from proteins C08H1/00; preparation of glue or gelatine C09H; single cell proteins, enzymes C12N; genetic engineering processes for obtaining peptides C12N15/00; compositions for measuring or testing processes involving enzymes C12Q; investigation or analysis of biological material G01N33/00)

## Abstract

This invention provides a novel probe, which contains a prostate peptide substrate. The probe can be used as a prostate diagnostic agent for optical imaging. An 11 amino acid peptide substrate is synthesized for specific prostate-specific antigen (PSA). This protected graft copolymer (PGC) consists of a poly-L-lysine (PL) backbone and methoxypoly(ethylene glycol) (MPEG). Two terminals of peptide substrate are bound to poly-L-lysine and Cy5.5 fluorochrome. This probe will be used as a NIR (near-infrared fluorescence) probe for optical imaging.

## Claims

### Claim 1

A prostate peptide substrate having the following formula:
Gly-Hyp-Ala-Ser-Chg-Gln-Ser-Leu-Met-Lys(FITC)-Cys-NH2

### Claim 2

A peptide substrate probe having the following formula (I):
D-Gly-Hyp-Ala-Ser-Chg-Gln-Ser-Leu-Met-Lys(FITC)-Cys-P (I)
wherein,
D is one selected from the group consisting of Cy5.5, Cy5, Cy7 and Alexa 750, Alexa 660, Alexa 680, IR 800, a lanthanum series metal complex and a near-infrared fluorescence dye;
P is one selected from the group consisting of a polysaccharide, a polylysine, a polyethylene imine and a synthetic polymer.

### Claim 3 (depends on 2)

The peptide substrate probe of claim 2, wherein the peptide substrate probe is used as a prostate diagnostic agent for optical imaging.

### Claim 4 (depends on 2)

The peptide substrate probe of claim 2, wherein the peptide substrate probe can be cut by a prostate-specific antigen.

### Claim 5

A method for diagnosing a human prostatic cancer comprising the steps of:
(a) synthesizing a prostate peptide substrate and a control peptide;
(b) synthesizing a prostate peptide substrate probe and a prostate control peptide probe; and
(c) diagnosing the human prostatic cancer with the prostate peptide substrate probe and the prostate control peptide probe.

### Claim 6 (depends on 5)

The method of claim 5, wherein the diagnosing is achieved through a preparation of a prostate diagnostic agent for optical imaging.

### Claim 7 (depends on 1)

A prostatic cancer probe comprising a prostate peptide substrate of claim 1.

### Claim 8 (depends on 7)

The prostatic cancer probe of claim 7 useful for diagnosing an in-vivo prostatic cancer through a preparation of a prostate diagnostic agent for optical imaging.
